!

URGENT: SB 432, which will enable Big Pharma to raise drug costs even higher, just moved one step closer to passing. 

Study Finds Pharma Dollars Directly Linked to Opioid Deaths

February 14, 2019

Targeted marketing is a strategy companies use to increase sales of a product or service. The theory is that the more times you see or interact with an advertisement, the more likely you are to purchase the advertised product.

But what happens when those strategies evolve from pushing electronics, clothes, and appliances? What happens when those strategies start pushing potentially dangerous and habit-forming medications?

According to a new study announced in the Journal of the American Medical Association (JAMA) Network Open and reported by CNN, there is a direct correlation between marketing efforts promoting opioids and fatal opioid-related overdoses.

The study found that for every 1,000 residents of an area, opioid prescribing rates soared more than 180%. One of the more shocking developments noted by researchers was the way in which pharmaceutical companies targeted physicians and the weight these exchanges carried.

Free lunches, speaking fees, and travel compensation—or what researchers called “marketing interactions”—were just some of the ways these pharmaceutical companies used their influence to generate more prescriptions. And that influx of prescriptions had dire consequences for its recipients.

Some analysis has the current opioid mortality rate at a level that is five times higher than it was 20 years ago through growth that has progressed in three stages. While there appeared to be a slower rate of increase from 2006 to 2014, opioid-related deaths have skyrocketed over the last five years.

That increase coincides with details uncovered by researchers who dug deep into the dollars spent promoting opioids.

Data obtained from the Centers of Medicare and Medicaid Services Open Payments database found pharmaceutical companies made 435,000 payments to more than 67,000 physicians across the country from August 2013 through December 2015. The collective sum of these payments exceeded a whopping $39 million.

The groundbreaking study is the first of its kind to connect marketing spend from pharmaceutical companies with the number of opioid prescriptions and subsequent fatal overdoses.

The study’s lead author noted how something so seemingly innocent as a free $20 lunch, when compounded over time with multiple free lunches, can have a direct impact on a physician’s decision to prescribe opioids.

When evaluating for geographic patterns, researchers found the bulk of the marketing dollars directed toward doctors located in the Northeast, while efforts toward doctors in the Midwest were minimal. More specifically, doctors based in urban, metropolitan areas received the most marketing interactions.

Those targets make sense considering the demographics of your average metropolitan resident compared to that of someone who lives in a more rural area. Those people are more likely to have insurance that makes the prescriptions more affordable. Urban areas also generally have a higher number of per capita healthcare providers and hospitals.

Oddly enough, reports indicate that rural counties still had higher rates of prescribing opioids.

In 2017, the United States had more than 70,000 drug overdose deaths, of which opioids (both legal and illegal drugs) was among the leading causes. Overdose deaths related to prescription opioid use occurred in nearly a quarter of all overdose deaths in 2017.

Have the sky-high costs of healthcare in our state impacted you and/or your family’s lives? Do you want to do something about it? Join the Coalition now to receive updates about new legislation and policies that will affect YOUR healthcare. Sign up now!

!
Action Needed

Tell your representative to say "no" to higher drug costs

We’ve told you about big Pharma’s brazen attempt to gut the last remaining protection for patients against runaway drug prices.

Now the most profitable industry in the world is quietly pushing a bill through the state legislature that would cripple pharmacy benefit managers (PBMs), which negotiate lower drug costs for North Carolinians.

We cannot let big pharma use the law to eliminate our only advocate in price negotiations.


Comment on This Article   

Post Your Comment

Please check your e-mail for a link to activate your account.

Related Articles

Insys Therapeutics Admits to Bribing Doctors to Write Opioid Prescriptions
Federal Judge’s Ruling Deals Blow to Quest for Drug Price Transparency
AARP: Specialty Drug Costs Greatly Exceeding Median U.S. Household Income

Featured Articles

Tell your representative to say "no" to higher drug costs
SB 432 – Lots of Treats for Pharmacists – and Bad News for Consumers
Why do Pharmaceutical Companies hate PBMs so much?
AARP: Specialty Drug Costs Greatly Exceeding Median U.S. Household Income
Pharma Company Increases Drug Price by 909% as Wholesale Rates Soar
Podcast: Senator Joyce Krawiec Talks to Us About Why CON Laws are Bad for NC